The quest for a Covid-19 vaccine may have started in the laboratories but that’s only the start of a long process that involves the government and private sector working on the other issues that bridge the gap from lab to jab — from manufacturing and manpower to logistics and distribution priorities.
That is why most of those involved in the race for a vaccine are studiously non-committal about a timeline. The 2020-end deadline that is being bandied about in the public domain is purely speculative.
Balram Bhargava, chief of Indian Council of Medical Research, in a recent interview with Business